Skip to main content
. 2022 Nov 10;5(11):e2241338. doi: 10.1001/jamanetworkopen.2022.41338

Table 2. Health System Engagement by Study Group.

Time Participants with any, % Group differencea
LINKAGE group Usual care group RR (95% CI) P value
Substance use discussion with primary care practitionerb
Year 1 89/186 (47.8) 72/194 (37.1) 1.30 (1.03-1.65) .03
Year 2 62/164 (37.8) 56/166 (33.7) 1.14 (0.85-1.53) .39
Year 3 NA NA NA NA
Year 4 NA NA NA NA
Year 5 24/122 (19.7) 17/116 (14.7) 1.33 (0.76-2.33) .33
All yearsc 124/209 (59.3) 109/217 (50.2) 1.20 (0.99-1.45) .07
Annual electronic patient portal login
Year 1 181/206 (87.9) 144/221 (65.2) 1.34 (1.20-1.50) <.001
Year 2 139/175 (79.4) 123/182 (67.6) 1.17 (1.03-1.33) .01
Year 3 127/164 (77.4) 119/164 (72.6) 1.06 (0.93-1.20) .38
Year 4 117/153 (76.5) 105/144 (72.9) 1.05 (0.92-1.19) .51
Year 5 120/152 (78.9) 105/141 (74.5) 1.07 (0.94-1.21) .32
All yearsc 181/206 (87.9) 144/221 (65.2) 1.18 (1.08-1.29) <.001
Online medication refills
Year 1 164/206 (79.6) 100/221 (45.2) 1.75 (1.49-2.06) <.001
Year 2 119/175 (68.0) 97/182 (53.3) 1.27 (1.07-1.51) .01
Year 3 105/164 (64.0) 93/164 (56.7) 1.13 (0.94-1.34) .19
Year 4 98/153 (64.1) 83/144 (57.6) 1.12 (0.93-1.34) .24
Year 5 98/152 (64.5) 75/141 (53.2) 1.22 (1.01-1.49) .04
All yearsc 192/225 (85.3) 158/230 (68.7) 1.38 (1.22-1.56) <.001
Secure electronic messages sent to health care professional
Year 1 144/206 (69.9) 115/221 (52.0) 1.34 (1.15-1.57) <.001
Year 2 116/175 (66.3) 98/182 (53.8) 1.24 (1.04-1.47) .02
Year 3 106/164 (64.6) 92/164 (56.1) 1.16 (0.97-1.38) .10
Year 4 98/153 (64.1) 88/144 (61.1) 1.05 (0.88-1.25) .59
Year 5 100/152 (65.8) 85/141 (60.3) 1.09 (0.91-1.30) .35
All yearsc 186/225 (82.7) 165/230 (71.7) 1.18 (1.05-1.33) .01

Abbreviations: ED, emergency department; NA, not applicable; RR, risk ratio.

a

Group differences were estimated from a modified Poisson regression model per follow-up time point, adjusting for baseline age, Charlson Comorbidity Index, and emergent-type ED use.

b

Telephone interviews were conducted at 1, 2, and 5 years after study enrollment.

c

Group differences were estimated from a modified Poisson generalized estimating equations model, adjusting for (linear) time and baseline age, Charlson Comorbidity Index, and emergent-type ED use.